Glucose-6-phosphate dehydrogenase (G6PD), the first regulatory enzyme in the PPP, is significantly upregulated in patients with HF, resulting in increased superoxide production, which can be suppressed by inhibitors of NOX and G6PD (Gupte et al., 2007). The gene discussed is G6PD; the disease is hydrops fetalis.